| Literature DB >> 32287591 |
Ana Maria de Roda Husman1, Jamie Bartram2.
Abstract
This chapter illustrates the recommendations and guidelines of the World Health Organization (WHO) concerning water, sanitation, and health. The recommendations and guidelines are evaluated in the light of disease caused by human pathogenic viruses. The guidelines outline a preventive management framework for safe drinking water. The framework includes health-based targets to assist national authorities who are normally responsible to set the targets for the protection of public health from risks by exposure to drinking water. Assessing the adequacy of systems, defining and monitoring control measures, and establishing management plans are the three components of the so-called water safety plans. Achievement of health-based targets may be verified by independent surveillance to assess the safety of the drinking water through additional verification or audit-based approaches. This framework for safe drinking water can be adapted according to environmental, social, economic, and cultural circumstances of drinking water provision on the national, regional, and local level. The chapter concludes that viruses could be considered as biocolloids with specific properties such as size, shape, structure, charge, composition, and genome. These viral characteristics determine their behavior in the environment, resistance to natural inactivation and treatment, and disinfection processes. For each (re-)emerging virus these properties may be known or could be assessed predicting the effectiveness of possible intervention measures for prevention of waterborne disease.Entities:
Year: 2007 PMID: 32287591 PMCID: PMC7119133 DOI: 10.1016/S0168-7069(07)17007-5
Source DB: PubMed Journal: Perspect Med Virol ISSN: 0168-7069
Fig. 1Framework for safe drinking water (WHO, 2004).
Health-based targets as applicable for microbial, e.g. viral, hazards
| Type of target | Nature of target | Typical applications | Assessment |
|---|---|---|---|
| Health outcome | |||
Epidemiology based | Reduction in detected disease incidence or prevalence | Microbial hazards with high measurable disease burden largely water associated | Quantitative microbial risk assessment |
Risk assessment based | Tolerable level of risk from contaminants in drinking water, absolute or as a fraction of the total burden by all exposures | Microbial hazards in situations where disease burden is low or cannot be measured directly | Public health surveillance and analytical epidemiology |
| Performance | |||
Generic performance target for removal of groups of microbes | Microbial contaminants | Compliance assessment through system assessment and operational monitoring | |
Customised performance targets for removal of groups of microbes | Microbial contaminants | Individually reviewed by public health authority; assessment would then proceed as above | |
Incomplete but informative list of virus types present in human excreta and secreta
| Faeces | Urine | Saliva | Tears | Sweat | Reference | |
|---|---|---|---|---|---|---|
| Adenovirus | + | + | + | + | ? | |
| Aichivirus | + | ? | ? | ? | ? | |
| Astrovirus | + | ? | ? | ? | ? | |
| Enterovirus | + | + | + | ? | ? | |
| Hepatitis A virus | + | ? | + | ? | ? | |
| Hepatitis C virus | + | ? | + | ? | + | |
| Hepatitis E virus | + | ? | ? | ? | ? | |
| Norovirus | + | ? | ? | ? | ? | |
| Parvovirus | ? | ? | + | ? | ? | |
| Picobirnavirus | + | ? | ? | ? | ? | |
| Polyomavirus | + | + | ? | ? | ? | |
| Reovirus | + | ? | ? | ? | ? | |
| Rotavirus | + | ? | ? | ? | ? | |
| Sapovirus | + | ? | ? | ? | ? | |
| SARS coronavirus | + | + | + | ? | + | |
| TT virus | + | – | + | + | – |
Note: +, studied and confirmed; –, studied but not detected; ?, no studies included in publications shown by search engine NCBI PubMed.
Disease outcomes of human pathogenic viruses
| Disease outcome | Causative viral agent | Reference |
|---|---|---|
| Conjunctivitis | Adenovirus, enterovirus | |
| Gastroenteritis | Adenovirus, aichivirus, astrovirus, enterovirus, norovirus, picobirnavirus, rotavirus, sapovirus | |
| Hepatitis | Hepatitis A–G virus, TT virus | |
| Leukoencephalopathy | Polyomavirus | |
| Meningitis | Enterovirus, reovirus | |
| Myocarditis | Adenovirus, enterovirus, parvovirus | |
| Poliomyelitis | Enterovirus | |
| SARS | SARS coronavirus |
Characteristics of human pathogenic viruses and their possible indicators (Ferguson et al., 2003)
| Virus type | Size (nm) | pI | Phage type | Size (nm) | pI |
|---|---|---|---|---|---|
| Poliovirus 1 | 29 | 7.2 | PM2 | 60 | 7.3 |
| Poliovirus 2 | 29 | 4.5–6.5 | PM2 | 60 | 7.3 |
| Coxsackie virus A/B | 29 | 6.6-8.2 | ΦX174, PM2 | 26–32, 60 | 6.6, 7.3 |
| ECHO virus | 29 | 5.3–6.4 | ΦX174, Qβ | 26–32, 24 | 6.6, 5.3 |
| Hepatitis A virus | 27 | 2.8 | MS2 | 26 | 3.9 |
| Hepatitis E virus | 30 | – | – | – | – |
| Norovirus | 25 | 4.9♯ | Qβ, PRD1 | 24, 63 | 5.3, 4.2 |
| Sapovirus | 34 | – | – | – | – |
| Reovirus | 75 | 3.9 | MS2 | 26 | 3.9 |
| Rotavirus | 70 | – | – | – | – |
| Astrovirus | 29 | – | – | – | – |
| Adenovirus | 60–80 | – | – | – | – |
Note: ECHO, enteric cytopathogenic human orphan; Reo, respiratory enteric orphan; –, unknown; nm nanometer; pI, isoelectric point; ♯, determined for Norwalk-like virus particles.
Fig. 2Parameters that control virus behaviour in drinking water distribution systems. Viral inactivation was considered as follows. ‘Inactivation W’ corresponds to the inactivation of virus in the water phase; ‘Inactivation B’ corresponds to the inactivation of virus in biofilm; ‘Inactivation BW’ corresponds to the inactivation of virus entrapped or attached to biofilm and released into the water phase by sloughing or erosion. Solid hexagon, free or particle-associated virus that is able to infect target cells; open hexagon, free or particle-associated virus that is not able to multiply anymore. From Skraber et al. (2005).
Infectivity of specific waterborne virus variants
| Organisms | Symptom scored | ID50 | |
|---|---|---|---|
| Rotavirus | Excretion | 2.65×10−1 | 6.11 |
| Echovirus 12 | Excretion | 1.76×10−3 | 1.05×103 |
| Poliovirus | |||
| 1 sm | Excretion | 3.88×10−1 | 1.411 |
| 1 LSc2ab | Excretion | 7.14×10−4 | 6.93×104 |
| 1 | Excretion | 9.10×10−3 | 76.2 |
| 3 Fox (infants) | Excretion | 1.90×10−1 | 5.513 |
| 3 Fox (premature) | Excretion | 2.66×10−1 | 5.05 |
Source: From Teunis et al. (1996).
Note:, conditional probability of infection; ID50, number of microorganisms required to cause infection in 50% of experimentally infected animals, a measure of infectivity.
Administered in pH-buffered solution.
Rejected at the 95% level, within 99% confidence range for the deviance from maximum possible likelihood.